News Column

BioScale Introduces New 6-plate Cartridge Format for Its Acoustic Assays Assays

May 30, 2014

BioScale said it has launched a new, 6-plate cartridge format for its Acoustic Assays to enable larger protein analysis studies, with cost efficiency.

According to a company release, the product enhancement, for use on the company's proprietary ViBE instrumentation platform, was introduced at the American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference in San Diego.

"Our ViBE platform, paired with our non-optical Acoustic Assays, overcomes limitations of traditional methods like ELISA or Western blot by providing a simple, highly sensitive method of measuring specific proteins in a complex sample, with walk-away automation. This enables fast assay development - that takes days, rather than months," said Christopher Silva, VP, Commercial Operations at BioScale. "Now, our new 6-plate format enables even larger studies - providing up to 576 data points in one cartridge - at a cost as low as only $2 per sample well. This will be particularly important for scientists needing to study cell signaling pathways and biomarkers, who are running larger cohorts in the areas of oncology, CNS, cardiovascular and inflammation research - areas where the platform is currently utilized."

BioScale said its ViBE platform enables non-optical, acoustic protein measurement utilizing BioScale's proprietary AMMP (Acoustic Membrane MicroParticle) technology. The company's Acoustic Assays measure analyte concentration by determining changes in oscillation frequency caused by the binding of microparticles to the sensor surface. To date, the platform featured 1-, 2- and 3-plate cartridge formats allowing up to 288 samples per cartridge. Now, the 6-plate format allows up to 576 individual data points in a single assay or the re-use of the cartridge for multiple assays for up to 576 measurements across 5 days.

"BioScale's new 6-plate cartridge allows us to run more than 500 samples in a week, with a simple pipette-and-go workflow, dramatically increasing the accuracy of our study results," said Cloud Paweletz, Ph.D., of the Belfer Institute for Applied Cancer Science at the Dana Farber Cancer Institute, who beta tested the new product.

More Information:

((Comments on this story may be sent to

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Professional Services Close - Up

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters